Literature DB >> 15899316

Adherence, stereotyping and unequal HIV treatment for active users of illegal drugs.

Norma C Ware1, Monique A Wyatt, Toni Tugenberg.   

Abstract

Adherence to antiretroviral therapy promotes viral suppression and extends the lives of individuals with HIV, yet illegal drug users are underrepresented among eligible persons receiving HIV treatment. One explanation for this is the assumption that drug users are less capable than others of adhering to complicated medication regimens. This paper investigates this assumption by making explicit a number of its underlying propositions and examining them in light of data collected from 52 active drug users living in and around Boston, USA, who were taking highly active antiretroviral therapy for HIV (HAART). The propositions are: (1) drug users lead "chaotic" lives; (2) active drug users are always using drugs; (3) being under the influence of drugs precludes taking medications as prescribed; and (4) drug users are intrinsically different from non-users in the lives they lead and the problems they face. Data collection consisted of a series of qualitative interviews with each participant. An analytic approach informed by grounded theory was used to construct thematic content categories from the data. Results revealed stability and control as well as "chaos" in the lives of study participants. Frequency of drug use varied considerably. Using did interfere with adherence, but not in every circumstance or all cases. Not "carrying" medications, competing priorities, and re-defining regimens were the most salient of a number of non-drug-use-related obstacles observed. Documentation of patterns of variation in corresponding data highlights the stereotypical quality of the propositions. Stereotyping risks overemphasis on drug use as a barrier to adherence for active users, and underemphasis on non-drug-use-related obstacles. Adherence capabilities of users, in contrast to inadequacies, are also obscured through stereotyping. As a medium for stigmatization, stereotyping may contribute to unequal treatment for drug users and other populations living with HIV.

Entities:  

Mesh:

Year:  2005        PMID: 15899316     DOI: 10.1016/j.socscimed.2004.12.015

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  18 in total

1.  Social stability and health: exploring multidimensional social disadvantage.

Authors:  Danielle German; Carl A Latkin
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

2.  Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.

Authors:  James C M Brust; Alain H Litwin; Karina M Berg; Xuan Li; Moonseong Heo; Julia H Arnsten
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

Review 3.  How qualitative methods contribute to understanding combination antiretroviral therapy adherence.

Authors:  Andrea Sankar; Carol Golin; Jane M Simoni; Mark Luborsky; Cynthia Pearson
Journal:  J Acquir Immune Defic Syndr       Date:  2006-12-01       Impact factor: 3.731

Review 4.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

5.  Associations among correlates of schedule adherence to antiretroviral therapy (ART): a path analysis of a sample of crack cocaine using sexually active African-Americans with HIV infection.

Authors:  J S Atkinson; L Nilsson Schönnesson; M L Williams; S C Timpson
Journal:  AIDS Care       Date:  2008-02

6.  Enhancing Patient Adherence: Promoting Engagement via Positive Patient-Provider Relationships in HIV/AIDS Care.

Authors:  Leah Farrell; Karen Ingersoll; Sherry Dyche Ceperich
Journal:  Med Encount       Date:  2009

7.  "It is easier for me to shoot up": stigma, abandonment, and why HIV-positive drug users in Russia fail to link to HIV care.

Authors:  Tetiana Kiriazova; Karsten Lunze; Anita Raj; Natalia Bushara; Elena Blokhina; Evgeny Krupitsky; Carly Bridden; Dmitry Lioznov; Jeffrey H Samet; Allen L Gifford
Journal:  AIDS Care       Date:  2016-11-22

8.  Prevalence and Correlates of Reporting Difficulty Taking Antiretroviral Treatment Among HIV-Positive Illicit Drug Users in Vancouver, Canada: A Longitudinal Analysis.

Authors:  Bianca Yeung; N A Mohd Salleh; Eugenia Socías; Huiru Dong; J Shoveller; J S G Montaner; M-J S Milloy
Journal:  AIDS Behav       Date:  2019-05

9.  Lipid-Lowering Therapy in HIV-Infected Patients: Relationship with Antiretroviral Agents and Impact of Substance-Related Disorders.

Authors:  Cindy Bednasz; Amneris E Luque; Barry S Zingman; Margaret A Fischl; Barbara M Gripshover; Charles S Venuto; Jie Gu; Zekun Feng; Robin DiFrancesco; Gene D Morse; Qing Ma
Journal:  Curr Vasc Pharmacol       Date:  2016       Impact factor: 2.719

10.  The association between life chaos, health care use, and health status among HIV-infected persons.

Authors:  Mitchell D Wong; Catherine A Sarkisian; Cynthia Davis; Janni Kinsler; William E Cunningham
Journal:  J Gen Intern Med       Date:  2007-06-28       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.